Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-02-011142
Filing Date
2002-03-22
Accepted
2002-03-22 00:00:00
Documents
8
Period of Report
2001-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2073973z10-k.htm 10-K 533487
3 EX-10.7 a2073973zex-10_7.txt EX-10.7 28417
4 EX-10.21 a2073973zex-10_21.txt EX-10.21 100070
5 EX-10.28.5 a2073973zex-10_285.txt EX-10.28-5 8700
6 EX-10.28.6 a2073973zex-10_286.txt EX-10.28-6 9532
7 EX-21 a2073973zex-21.txt EX-21 744
8 EX-23 a2073973zex-23.txt EX-23 861
9 EX-99 a2073973zex-99.txt EX-99 29692
  Complete submission text file 0000912057-02-011142.txt   713765
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GENZYME TRANSGENICS CORP (Filer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0103
Type: 10-K | Act: 34 | File No.: 000-21794 | Film No.: 02582640
SIC: 2836 Biological Products, (No Diagnostic Substances)